> ## Content Index
> Fetch the complete content index at: https://www.bullished.co/llms.txt
> Use this file to discover other available public pages before exploring further.

# Neogen Holders Approve Equity Plan Covering Up To 31,350,000 Shares
- URL: https://www.bullished.co/neogen-holders-approve-equity-plan-covering-up-to-31-350-000-shares-99e59004/
- Published: 2026-10-26T13:36:06.000Z
- Updated: 2026-10-28T16:58:26.000Z
- Description: The restated incentive plan, approved at the October 1 annual meeting, reaches directors and every employee, executives included.
- Author: Matteo Parrino
- Tags: SEC Filings, NEOG, Industry: Healthcare

[Neogen](https://www.bullished.co/tag/neog/) shareholders approved a restated incentive plan that allows up to [31,350,000 shares](https://www.sec.gov/Archives/edgar/data/0000711377/000119312526431208/neog-20261001.htm?ref=bullished.co) to be issued as equity awards, the company has now disclosed in an amended filing made Monday. The vote took place at the October 1 annual meeting; Neogen, which makes food-safety and animal-safety test kits and related products, added the disclosure to an earlier [8-K](https://www.bullished.co/learn/8-k-items-explained/).

## Who can receive awards

The Amended and Restated Omnibus Incentive Plan covers non-employee directors and all employees of Neogen or its subsidiaries, named executive officers among them. The 31,350,000-share ceiling is subject to certain adjustments, the company said.

Awards can take several forms: stock options, stock appreciation rights, restricted stock and restricted stock units, performance stock units, and other stock-based awards.

The plan amends and restates Neogen's existing 2023 Omnibus Incentive Plan, which shareholders had approved earlier. A proxy statement filed with the SEC on August 21, 2026 described it in more detail and attached the plan text.

## An amendment to the October 7 filing

The new filing, an 8-K/A, amends the [original 8-K filed October 7](https://www.sec.gov/Archives/edgar/data/0000711377/000119312526416247/neog-20261001.htm?ref=bullished.co) to add the compensation disclosure about the plan's approval. Beyond that addition, it leaves the original report unchanged.

## The business and the stock

Neogen's Food Safety segment sells diagnostic test kits, culture media and software to food and feed producers, labs and regulators. Its Animal Safety segment sells veterinary instruments, pharmaceuticals, vaccines, rodent and insect control products, drug detection tests and genomics testing. As of May 31, 2026, the company employed 2,636 people worldwide.

Neogen shares traded at $12.21 in Monday trading, up about 0.16% from the prior close.

Every employee is eligible for awards from the pool of 31,350,000 shares, up to that cap.

Learn

- [8-K Items Explained: What Every Item Code From 1.01 To 9.01 Tells You, With Examples →](https://www.bullished.co/learn/8-k-items-explained/)  
What every common 8-K item means, from 1.01 to 9.01: which are routine, which are rare, what to check, with real examples and counts from 90 days of filings.

### Sources

- [8-K/A Filing (Amendment) — NEOGEN CORP (NEOG)](https://www.sec.gov/Archives/edgar/data/0000711377/000119312526431208/neog-20261001.htm?ref=bullished.co) — SEC EDGAR
- [Original 8-K — NEOGEN CORP (filed 2026-10-07)](https://www.sec.gov/Archives/edgar/data/0000711377/000119312526416247/neog-20261001.htm?ref=bullished.co) — SEC EDGAR

### More on Neogen

- [Neogen's 10-Q Drops Its Closing Target For The Zoetis Genomics Sale; Two Regulators Now Run To December](https://www.bullished.co/neogens-10-q-drops-its-closing-target-for-the-zoetis-genomics-sale-two-regulators-now-run-c26126c6/)
- [Neogen Lifts Fiscal 2027 Revenue Outlook To $885 Million-$890 Million Despite $11.9 Million Quarterly Loss](https://www.bullished.co/neogen-lifts-fiscal-2027-revenue-outlook-to-885-million-890-million-despite-11-9-million-86cb4a21/)

[All Neogen (NEOG) coverage →](https://www.bullished.co/tag/neog/)